{"name":"Laurus Labs","slug":"laurus","ticker":"LAURUSLABS.NS","exchange":"NSE","domain":"lauruslabs.com","description":"Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.","hq":"Hyderabad, India","founded":2005,"employees":"6167","ceo":"Satyanarayana Chava","sector":"API / CDMO / Anti-Retrovirals / Oncology","stockPrice":1082.45,"stockChange":25,"stockChangePercent":2.36,"marketCap":"$584.5B","metrics":{"revenue":67216297984,"revenueGrowth":25.7,"grossMargin":57,"rdSpend":0,"netIncome":8433200128,"cash":633800000,"dividendYield":15,"peRatio":69.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Lopimune patent cliff ($100.0M at risk)","drug":"Lopimune","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Laurus Labs Reports Strong Q3 FY2024 Results","summary":"Laurus Labs announced its Q3 FY2024 earnings, reporting a significant increase in revenue and profitability.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"deal","headline":"Laurus Labs Partners with Cipla for API Supply","summary":"Laurus Labs entered into a partnership with Cipla to supply APIs for the Indian market.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9wMEZQRjNVa1Yxc1Ftc24xN1g3RXN4Y0lqNUlIX3lZVzdSNlBlM1hhemJQVzh3a0FjRnFhYi1pTGc3SEFHNWUtZEZVRTh3dVVBLVQzalJ2ZlY?oc=5","date":"2026-01-24","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Viyash Scientific Limited (VIYASH.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Viyash Scientific Limited (VIYASH.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOVVdlTnpHbXpTMThTVWZSYnJLc1JhSVAzYVByUHQzV1hoS0dJYTB0X29yZTVxOS13RC0tMEJBVUc2UXEzb2FEZVpaUTJvTDdhN0VEU29nR09HTkxDaThfLTFlSGZHUzU1TWY5Y2Fab1I1WlNOOEhoMUlEajBndEpsZFVvOVh5UmZXaUR1SXhxWVV4d21uR2ZoVA?oc=5","date":"2025-10-08","type":"pipeline","source":"Yahoo Finance","summary":"Aarvik Therapeutics Announces Investment by Laurus Labs in Aarvik Series Seed 2 Round - Yahoo Finance","headline":"Aarvik Therapeutics Announces Investment by Laurus Labs in Aarvik Series Seed 2 Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFB4QW5EdHRvOGtlWjN2Qzh3dXBQb3kwQnV6YjR6S0pnOWFIRDA1YXVDNnFVZGNUM3RodEFXUmZKbWZkU2ZzbGFGQ1pHY2RfRnZNQlh1YUprREpseW1yd1V3MWE4SzJ3WjFl?oc=5","date":"2024-09-18","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Laurus Labs Limited (LAURUSLABS.NS) company profile and facts - Yahoo Finance Singapore","headline":"Laurus Labs Limited (LAURUSLABS.NS) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE82X0JMTVZkOUhDVWJYa0dvYnlGVnc1bkxQbERJbkRlUzF2YWx1SlBzMDVsQjFZREdGZVBYbzI4SlJtN1JfdURyaEpWdlB6bjZsNVFVRGJUMnNpUjlZelE?oc=5","date":"2022-05-02","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Laurus Labs Limited (LAURUSLABS.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Laurus Labs Limited (LAURUSLABS.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFAzbkNNUkFQYlB5S21oeVFvbjNDTjJkeWRqTHFkWlJkNTByMVhuNExxdEZyNTVyMl96Rm1RN1dGWDRScHR2bktFRUl1NEIzU25KYVZjWWo0NmNJREUwdFJEdmQ5eHRsZDIy?oc=5","date":"2018-08-28","type":"pipeline","source":"Yahoo Finance UK","summary":"Torrent Pharmaceuticals Limited (TORNTPHARM.BO) company profile and facts - Yahoo Finance UK","headline":"Torrent Pharmaceuticals Limited (TORNTPHARM.BO) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE13Y2Q0bXdqQXdrTXZuUlZEbWVkZTlfdjV2SlY0dkJGaURISDZGakUtYzFxakhDWEJNTUVkOE1WaFNRNTJvSVoydS16TDJ5cWRUWHNCSDZFZUF1ZjRHTEE?oc=5","date":"2018-07-18","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Neuland Laboratories Limited (NEULANDLAB.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Neuland Laboratories Limited (NEULANDLAB.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5UTnUwSDlleGFSQXdqNDdPVXVYdklUNmg3bEJxaTNxV2lTNkFYX0dHdkVGejlpLU5yemRqcTEtd3hPRllSZHhhUExfSlBsUEY4M2tGVW93RmVFMVk?oc=5","date":"2017-06-22","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Divi's Laboratories Limited (DIVISLAB.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Divi's Laboratories Limited (DIVISLAB.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9kbWN1aGxhS0h6SkNxZFlJLUl1VldUOWZQU042X0FKRUJNU2NKN0x1V012a3d1RDRMMUxUQmlWMHNBX0lPZEhNQ25EUmNzUkkzTVYwaDRqMmkwaHBxa1E?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE04WnpqNWd4eU41TWRjZmpBWnoxWF9ycjJfcTBZNzBnTnpRUEFHeDU0SmVoZEh4SER6c1JsUVp1VF82cEVld1VzOGZxNDgyZnhZelUySXpnQ3pnRTFGYXc?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Morepen Laboratories Limited (MOREPENLAB.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Morepen Laboratories Limited (MOREPENLAB.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1kX0ZKRjUxVkM1SWNEMDRsNUpURTIyYXBtU3FRN0lTT2ZORTdWMVdDTTFqaTZaWnd6MWhWTkFtb1ZGYkFYV2VIMnR3LU1HMGdRRmprbmlRcUNDUQ?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Nectar Lifesciences Limited (NECLIFE.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Nectar Lifesciences Limited (NECLIFE.NS) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Lopimune","drugSlug":"lopinavir/ritonavir","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Aurobindo Pharma","Dr. Reddy's Laboratories","Cipla"],"therapeuticFocus":["Anti-Retrovirals","Oncology"],"financials":null,"yahoo":{"currentPrice":1082.45,"previousClose":1057.45,"fiftyTwoWeekHigh":1141,"fiftyTwoWeekLow":551,"fiftyTwoWeekRange":"551.0 - 1141.0","fiftyDayAverage":1008.87,"twoHundredDayAverage":952.61,"beta":0.34,"enterpriseValue":592610721792,"forwardPE":58.2,"priceToBook":12.17,"priceToSales":8.7,"enterpriseToRevenue":8.82,"enterpriseToEbitda":35.75,"pegRatio":0,"ebitda":16575699968,"ebitdaMargin":24.7,"freeCashflow":0,"operatingCashflow":0,"totalDebt":22117599232,"debtToEquity":44.8,"currentRatio":0,"returnOnAssets":0,"returnOnEquity":0,"analystRating":"2.9 - Hold","recommendationKey":"hold","numberOfAnalysts":14,"targetMeanPrice":968.86,"targetHighPrice":1270,"targetLowPrice":510,"dividendRate":1.6,"payoutRatio":0.1,"fiveYearAvgDividendYield":0.33,"exDividendDate":1761868800,"insiderHeldPercent":32.2,"institutionHeldPercent":43.2,"sharesOutstanding":539856582,"floatShares":362627510,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":15.66,"epsForward":18.6,"revenuePerShare":124.69,"bookValue":88.97,"officers":[{"age":64,"name":"Dr. Satyanarayana  Chava M.Sc., Ph.D.","title":"CEO & Whole Time Director"},{"age":60,"name":"Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A.","title":"CFO & Whole-Time Director"},{"age":57,"name":"Mr. B. V. R. K. Suryadevara Srinivasa Rao","title":"President of Manufacturing and Operations"},{"age":null,"name":"Mr. Gogireddy Venkateswar Reddy","title":"VP of Legal, Compliance Officer & Company Secretary"},{"age":57,"name":"Mr. Narasimha Rao Chava","title":"Executive Vice President of Human Resources"},{"age":63,"name":"Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D.","title":"Executive Director of Quality & Executive Director"},{"age":62,"name":"Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc.","title":"Executive Vice President of Manufacturing"},{"age":52,"name":"Mr. Chagarlamudi Sita Ramaiah","title":"Executive Vice President of Finance"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.lauruslabs.com","phone":"91 40 3980 4333"}}